CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleMarket cap is $1.65B, above the global median of $1.15B
- FinancialsAltman Z-Score 3.26: safe zone
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.44%Below 5Y avg (1.83%)
Annual Rate
CNY 0.09Paid annual
Payout Ratio
0.0%Sustainable
Last Ex-Dividend
May 12, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
11.09BCNY1.65B · vs all stocks (USD)
Trailing P/E
91.25xRevenue (TTM)
3.50BCNY520.52M · vs all stocks (USD)
Profit Margin
3.67%Beta
0.4770xvs all stocks
52-Week Change
-11.30%vs all stocks
Market Capitalization
11.09BCNY1.65B · vs all stocks (USD)
Enterprise Value
12.47BCNY1.85B · vs all stocks (USD)
Trailing P/E
91.25xForward P/E
37.76xPrice to Sales (TTM)
3.40xPrice to Book (MRQ)
2.28xEnterprise to Revenue
3.56xEnterprise to EBITDA
24.14xGross Margin
30.60%Profit Margin
3.67%Operating Margin
4.95%Return on Assets (TTM)
1.15%Return on Equity (TTM)
1.14%Revenue (TTM)
3.50BCNY520.52M · vs all stocks (USD)
Revenue per Share (TTM)
6.18CNYUpdated Aug 19, 2026Quarterly Revenue Growth
10.60%Gross Profit (TTM)
1.06BCNY156.77M · vs all stocks (USD)
EBITDA (TTM)
607.65MCNY90.25M · vs all stocks (USD)
Net Income (TTM)
128.49MCNY19.08M · vs all stocks (USD)
Operating Cash Flow (TTM)
673.79MCNY100.07M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
283.67MCNY42.13M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.0900CNYUpdated Aug 19, 2026Trailing Annual Dividend Yield
0.44%vs all stocks
5-Year Average Dividend Yield
1.83%vs all stocks
Payout Ratio
0.00%Minority Interest (Equity)
147.44MCNYFY2025 · Dec 31, 2025Revenue
3.42BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
2.40BCNYFY2025 · Dec 31, 2025Gross Profit
1.02BCNYFY2025 · Dec 31, 2025Operating Income
211.03MCNY31.34M · vs all stocks (USD)
Pre-tax Income
82.68MCNYFY2025 · Dec 31, 2025Income Tax Expense
52.29MCNYFY2025 · Dec 31, 2025Net Income
30.39MCNYFY2025 · Dec 31, 2025EBIT
133.15MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
607.65MCNYFY2025 · Dec 31, 2025Research & Development
267.58MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
188.03MCNYFY2025 · Dec 31, 2025Other Operating Expenses
32.34MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
9.07MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
50.48MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.1800CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.1800CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
535.22MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
535.22MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
30.39MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
65.95MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
75.29MCNYFY2025 · Dec 31, 2025Free Cash Flow
-213.33MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
1.03BCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
30.39MCNYFY2025 · Dec 31, 2025Other Non-cash Items
126.35MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-80.21MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-1.24MCNYFY2025 · Dec 31, 2025Capital Expenditures
-288.61MCNYFY2025 · Dec 31, 2025Purchase of Investments
-2.26BCNYFY2025 · Dec 31, 2025Sale of Investments
1.87BCNYFY2025 · Dec 31, 2025Other Investing Activity
2.56MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-677.84MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
220.41MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-604.01MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-30.11MCNYFY2025 · Dec 31, 2025Other Financing Charges
-80.21MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-493.92MCNYFY2025 · Dec 31, 2025Shares Outstanding
543.44MSharesUpdated Aug 19, 2026Float Shares
326.31MSharesUpdated Aug 19, 2026% Held by Insiders
44.40%vs all stocks
% Held by Institutions
8.82%vs all stocks
Total Cash (MRQ)
1.35BCNY199.87M · vs all stocks (USD)
Total Cash per Share (MRQ)
2.42CNYUpdated Aug 19, 2026Total Debt (MRQ)
1.49BCNY221.03M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.2714xCurrent Ratio (MRQ)
1.85xBook Value per Share (MRQ)
9.61CNYUpdated Aug 19, 2026Total Assets
8.55BCNY1.27B · vs all stocks (USD)
Total Current Assets
3.27BCNYFY2025 · Dec 31, 2025Total Liabilities
3.05BCNYFY2025 · Dec 31, 2025Total Non-current Assets
5.28BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
1.26BCNYFY2025 · Dec 31, 2025Total Current Liabilities
1.80BCNYFY2025 · Dec 31, 2025Cash
1.12BCNYFY2025 · Dec 31, 2025Cash Equivalents
8.59MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
1.13BCNYFY2025 · Dec 31, 2025Other Short-term Investments
279.28MCNYFY2025 · Dec 31, 2025Accounts Receivable
762.37MCNYFY2025 · Dec 31, 2025Inventory
770.38MCNYFY2025 · Dec 31, 2025Accounts Payable
844.70MCNYFY2025 · Dec 31, 2025Short-term Debt
496.99MCNYFY2025 · Dec 31, 2025Other Current Liabilities
8.94MCNYFY2025 · Dec 31, 2025Long-term Debt
1.01BCNYFY2025 · Dec 31, 2025Common Stock (Book)
543.44MCNYFY2025 · Dec 31, 2025Retained Earnings
2.57BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
5.50BCNY816.58M · vs all stocks (USD)
Treasury Stock
29.87MCNYFY2025 · Dec 31, 202552-Week Low
13.24CNYUpdated Aug 19, 202652-Week High
30.40CNYUpdated Aug 19, 202652-Week Change
-11.30%vs all stocks
Beta
0.4770xvs all stocks
50-Day MA
16.75CNYUpdated Aug 19, 2026200-Day MA
20.85CNYUpdated Aug 19, 2026Avg 10-Day Volume
49.68MSharesUpdated Aug 19, 2026Avg 30-Day Volume
36.57MSharesUpdated Aug 19, 2026Diluted EPS (TTM)
0.2400CNYUpdated Aug 19, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 3.26: safe zoneNotable
Altman Z-Score: 3.26
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Market cap is $1.65B, above the global median of $1.15BNotable
Market cap (USD): 1,646,525,452.323Global Median: 1,146,734,693.424
Levered free cash flow is $42.13M, above the global median of $16.24MNotable
Levered free cash flow (USD): 42,131,008.214Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
MoonLake Immunotherapeutics
Tier 1ProductionApproval-Gated PipelineRuleRisk
Henan Lingrui Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Inner Mongolia Furui Medical Science Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Beijing Balance Medical Technology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Alembic Pharmaceuticals Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Ningbo Menovo Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Shanghai MicroPort Endovascular MedTech Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Cofoe Medical Technology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Jubilant Pharmova Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Zhejiang Conba Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule